800-TEMPLE-MED Request Appointment
SEARCH TEMPLE HEALTH

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) (PALM-ILD)

view all Clinical Trials

Overview

The primary objective of this study is to evaluate the effect of 24-weeks of once daily treatment with TPIP versus placebo on exercise capacity in adults with PH-ILD.

Clinical Trial Information

Protocol

TIRB# 33044

Phase

3

Condition(s)

Interstitial Lung Disease (ILD), Pulmonary Hypertension (PH), Pulmonary Vascular Disease

Investigator

Parth Rali, MD

Coordinator

N/A

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease